11233

530239

SUVEN

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SUVEN LIFE SCIENCES LTD Share Price Today

SUVEN LIFE SCIENCES LTD is currently trading at ₹264.45, down by ₹4.34 from the previous close. The stock touched an intraday high of ₹270.35 and a low of ₹261.10 during the latest trading session. Over the past one year, SUVEN LIFE SCIENCES LTD has delivered a return of 1.59%, while the stock has gained 15.24% in the last one month.

SUVEN LIFE SCIENCES LTD performance

Today’s low Today’s high
₹ 261.10 ₹ 270.35
₹ 266.50
52 week low 52 week high
₹ 124.11 ₹ 299.99
₹ 266.50
Open Price ₹ 265.15
Prev. Close ₹ 268.80
Volume (Shares) 1207802.00
Total traded value ₹ 3218.79
Upper Circuit ₹ 322.55
Lower Circuit ₹ 215.05
info

Investment Returns

Over 1 Month 15.24% Over 3 Months 73.78% Over 6 Months 39.46% Over 1 Year 1.59%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SUVEN LIFE SCIENCES LTD fundamentals


  • Market cap (Cr) 7,054.50
  • P/E Ratio (TTM) -127.31
  • Beta 1.21
  • Book Value / share 57.00
  • Return on equity -6.33%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -11.17
info icon alternate text
  • Market cap (Cr) 7,079.60
  • P/E Ratio (TTM) -127.31
  • Beta 1.17
  • Book Value / share 57.00
  • Return on equity -6.33%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) -11.17
info icon alternate text

SUVEN LIFE SCIENCES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 1.52
Operating Expense 19.47
Net Profit -11.17
Net Profit Margin (%) -734.86
Earnings Per Share (EPS) -0.50
EBITDA -9.43
Effective Tax Rate (%) 0.00
Particulars DEC 2025 (Values in Cr)
Revenue 2.81
Operating Expense 19.05
Net Profit -13.47
Net Profit Margin (%) -479.35
Earnings Per Share (EPS) -0.60
EBITDA -12.12
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.92
Operating Expense 20.14
Net Profit -15.45
Net Profit Margin (%) -1679.34
Earnings Per Share (EPS) -0.70
EBITDA -14.12
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 1.87
Operating Expense 17.23
Net Profit -14.78
Net Profit Margin (%) -790.37
Earnings Per Share (EPS) -0.68
EBITDA -13.41
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 1.47
Operating Expense 17.73
Net Profit -15.07
Net Profit Margin (%) -1025.17
Earnings Per Share (EPS) -0.69
EBITDA -13.72
Effective Tax Rate (%) 0.00
Particulars MAR 2026 (Values in Cr)
Revenue 7.11
Operating Expense 75.89
Net Profit -54.86
Net Profit Margin (%) -771.58
Earnings Per Share (EPS) -2.41
EBITDA -49.09
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 6.66
Operating Expense 64.46
Net Profit -47.08
Net Profit Margin (%) -706.90
Earnings Per Share (EPS) -2.16
EBITDA -41.21
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 11.69
Operating Expense 49.29
Net Profit -8.01
Net Profit Margin (%) -68.52
Earnings Per Share (EPS) -0.37
EBITDA -2.34
Effective Tax Rate (%) 11.09
Particulars MAR 2023 (Values in Cr)
Revenue 13.54
Operating Expense 48.12
Net Profit -20.13
Net Profit Margin (%) -148.67
Earnings Per Share (EPS) -1.13
EBITDA -13.30
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 11.84
Operating Expense 53.41
Net Profit -36.25
Net Profit Margin (%) -306.16
Earnings Per Share (EPS) -2.69
EBITDA -31.33
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 5.04
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -2323.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 12.38
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -951.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.21
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin -822.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share 6.61
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.04
EBITDA Margin -987.58
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.58
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.04
EBITDA Margin -535.53
Particulars MAR 2025 (Values in Cr)
Book Value / Share 36.66
ROE % -6.33
ROCE % -6.30
Total Debt to Total Equity 0.00
EBITDA Margin -692.04
Particulars MAR 2024 (Values in Cr)
Book Value / Share 38.77
ROE % -2.36
ROCE % -2.44
Total Debt to Total Equity 0.00
EBITDA Margin -122.16
Particulars MAR 2023 (Values in Cr)
Book Value / Share 39.14
ROE % -4.20
ROCE % -4.11
Total Debt to Total Equity 0.00
EBITDA Margin -154.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 32.74
ROE % -9.17
ROCE % -8.90
Total Debt to Total Equity 0.01
EBITDA Margin -297.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 28.66
ROE % -5.73
ROCE % -6.73
Total Debt to Total Equity 0.01
EBITDA Margin -168.40
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 37.72
Total Assets 135.18
Total Liabilities 135.18
Total Equity 109.98
Share Outstanding 21
Price to Book Ratio 3.09
Return on Assets (%) -118.90
Return on Capital (%) -146.15
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 163.97
Total Assets 284.90
Total Liabilities 284.90
Total Equity 270.04
Share Outstanding 21
Price to Book Ratio 2.57
Return on Assets (%) -36.88
Return on Capital (%) -38.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 184.28
Total Assets 388.91
Total Liabilities 388.91
Total Equity 375.31
Share Outstanding 21
Price to Book Ratio 1.24
Return on Assets (%) -30.41
Return on Capital (%) -31.51
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.52
Total Assets 108.03
Total Liabilities 108.03
Total Equity 96.14
Share Outstanding 14
Price to Book Ratio 2.83
Return on Assets (%) -112.92
Return on Capital (%) -126.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 46.64
Total Assets 128.41
Total Liabilities 128.41
Total Equity 108.00
Share Outstanding 12
Price to Book Ratio 2.46
Return on Assets (%) -56.18
Return on Capital (%) -65.99
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 19.96
Total Assets 808.89
Total Liabilities 808.89
Total Equity 799.51
Share Outstanding 21
Price to Book Ratio 3.09
Return on Assets (%) -5.82
Return on Capital (%) -5.89
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 153.44
Total Assets 851.48
Total Liabilities 851.48
Total Equity 845.37
Share Outstanding 21
Price to Book Ratio 2.57
Return on Assets (%) -0.94
Return on Capital (%) -0.95
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 173.95
Total Assets 860.44
Total Liabilities 860.44
Total Equity 853.44
Share Outstanding 21
Price to Book Ratio 1.24
Return on Assets (%) -2.33
Return on Capital (%) -2.36
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.14
Total Assets 486.35
Total Liabilities 486.35
Total Equity 475.97
Share Outstanding 14
Price to Book Ratio 2.83
Return on Assets (%) -7.45
Return on Capital (%) -7.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 38.59
Total Assets 415.38
Total Liabilities 415.38
Total Equity 401.65
Share Outstanding 12
Price to Book Ratio 2.46
Return on Assets (%) -5.44
Return on Capital (%) -5.62
Particulars MAR 2025 (Values in Cr)
Net Income -160.74
Cash from Operations -154.70
Cash from Investing 154.95
Cash from Financing -0.75
Net change in Cash 0.09
Free Cash Flow -117.43
Particulars MAR 2024 (Values in Cr)
Net Income -106.07
Cash from Operations -121.64
Cash from Investing 94.43
Cash from Financing -1.05
Net change in Cash -22.08
Free Cash Flow -121.64
Particulars MAR 2023 (Values in Cr)
Net Income -118.26
Cash from Operations -114.87
Cash from Investing -247.81
Cash from Financing 395.53
Net change in Cash 31.74
Free Cash Flow -111.98
Particulars MAR 2022 (Values in Cr)
Net Income -121.99
Cash from Operations -127.01
Cash from Investing -22.22
Cash from Financing 145.69
Net change in Cash -4.07
Free Cash Flow -107.24
Particulars MAR 2021 (Values in Cr)
Net Income -77.47
Cash from Operations -94.87
Cash from Investing 55.84
Cash from Financing 34.85
Net change in Cash -5.32
Free Cash Flow -88.57
Particulars MAR 2025 (Values in Cr)
Net Income -47.07
Cash from Operations -47.99
Cash from Investing 44.21
Cash from Financing -0.75
Net change in Cash -3.93
Free Cash Flow -10.71
Particulars MAR 2024 (Values in Cr)
Net Income -9.01
Cash from Operations -26.73
Cash from Investing -0.67
Cash from Financing -1.05
Net change in Cash -22.29
Free Cash Flow -26.73
Particulars MAR 2023 (Values in Cr)
Net Income -20.12
Cash from Operations -21.81
Cash from Investing -348.82
Cash from Financing 395.53
Net change in Cash 23.79
Free Cash Flow -18.92
Particulars MAR 2022 (Values in Cr)
Net Income -36.24
Cash from Operations -36.10
Cash from Investing -107.45
Cash from Financing 145.69
Net change in Cash 1.60
Free Cash Flow -16.33
Particulars MAR 2021 (Values in Cr)
Net Income -27.95
Cash from Operations -35.53
Cash from Investing 2.41
Cash from Financing 34.85
Net change in Cash 0.58
Free Cash Flow -29.23
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8303.55 61.03 12.60 119392.31 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 54.56 24.69 2.97 102.26 40.75 77.00
SHREE PACETRONIX LTD. 141.75 16.92 2.98 53.15 66.10 283.15
TRANSGENE BIOTEK LTD. 3.11 0.00 2.81 23.56 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8303.55 79.53 11.98 119392.31 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.80 0.00 -9.44 28.98 30.30 57.48
KOVAI MEDICAL CENTER & HOSPITA 5378.20 24.07 4.45 5883.75 5010.00 6725.00

SUVEN LIFE SCIENCES LTD shareholding pattern

Holding
24.32%
70.15%
0.9%
4.62%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

SUVEN LIFE SCIENCES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
267.50 1.15 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 255.70
  • 26 Days 245.40
  • 10 Days 258.10
  • 50 Days 223.60
  • 12 Days 257.60
  • 100 Days 201.70
  • 20 Days 251.40
  • 200 Days 190.80
269.28 PIVOT
First Support 259.57 First Resistance 276.07 Second Support 252.78 Second Resistance 285.78 Third Support 243.07 Third Resistance 292.57
RSI 46.90 ADX 39.89 MACD 15.78 Williams % R -68.68 Commodity Channel Index (CCI) -12.60
Date 2026-06-05 Week 903641.00 Same Day 973771.00 Month 541751.00
1 Year 1.13 3 Year 1.04
Over 1 Month
15.24% down
Over 1 Year
1.59% down
Over 3 Months
73.78% down
Over 3 Years
59.76% down
Over 6 Months
39.46% down
Over 5 Years
22.40% down

SUVEN LIFE SCIENCES LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
14 Feb 2019 1.5 Interim 15 Feb 2019 Equity shares
06 Feb 2018 1.5 Interim 07 Feb 2018 Equity shares
08 Feb 2017 1.0 Interim 09 Feb 2017 Equity shares
14 Mar 2016 1.0 Special 15 Mar 2016 Equity shares
14 Mar 2016 1.0 Interim 15 Mar 2016 Equity shares
23 Jul 2015 0.6 Final 25 Jul 2015 Equity shares
24 Jul 2014 2.0 Special 26 Jul 2014 Equity shares
24 Jul 2014 0.5 Final 26 Jul 2014 Equity shares
01 Aug 2013 0.3 Final 05 Aug 2013 Equity shares
17 Sep 2012 0.3 Final 19 Sep 2012 Equity shares
01 Aug 2011 0.25 Final 03 Aug 2011 Equity shares
19 Jul 2010 0.25 Final 21 Jul 2010 Equity shares
14 Sep 2009 0.25 Final 16 Sep 2009 Equity shares
11 Sep 2008 0.25 Final 13 Sep 2008 Equity shares
21 Sep 2007 0.25 Final 25 Sep 2007 Equity shares
25 Sep 2006 0.0 Final 27 Sep 2006 Equity shares
05 Sep 2005 0.0 Final 08 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
02 Apr 2007 23 Mar 2007 1:1
Ex-Date Old FV NEW FV Record Date
23 Mar 2007 2.0 1.0 02 Apr 2007
15 Jan 2004 10.0 2.0 23 Jan 2004
Dividend date Dividend amount Dividend type Record date Instrument type
14 Feb 2019 1.5 Interim 15 Feb 2019 Equity shares
06 Feb 2018 1.5 Interim 07 Feb 2018 Equity shares
08 Feb 2017 1.0 Interim 09 Feb 2017 Equity shares
14 Mar 2016 1.0 Special 15 Mar 2016 Equity shares
14 Mar 2016 1.0 Interim 15 Mar 2016 Equity shares
23 Jul 2015 0.6 Final 25 Jul 2015 Equity shares
24 Jul 2014 2.0 Special 26 Jul 2014 Equity shares
24 Jul 2014 0.5 Final 26 Jul 2014 Equity shares
01 Aug 2013 0.3 Final 05 Aug 2013 Equity shares
17 Sep 2012 0.3 Final 19 Sep 2012 Equity shares
01 Aug 2011 0.25 Final 03 Aug 2011 Equity shares
19 Jul 2010 0.25 Final 21 Jul 2010 Equity shares
14 Sep 2009 0.25 Final 16 Sep 2009 Equity shares
11 Sep 2008 0.25 Final 13 Sep 2008 Equity shares
21 Sep 2007 0.25 Final 25 Sep 2007 Equity shares
25 Sep 2006 0.0 Final 27 Sep 2006 Equity shares
05 Sep 2005 0.0 Final 08 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
02 Apr 2007 23 Mar 2007 1:1
Ex-Date Old FV NEW FV Record Date
23 Mar 2007 2.0 1.0 02 Apr 2007
15 Jan 2004 10.0 2.0 23 Jan 2004

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Suven Life Sciences Ltd?

Answer Field

Suven Life Sciences Ltd share price is for NSE ₹ 264.45 & for BSE ₹ 264.55 as on Jun 11 2026 10:15 AM.

What is the Market Cap of Suven Life Sciences Ltd Share?

Answer Field

The market cap of Suven Life Sciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 11 2026 10:15 AM.

What is the 52 Week High and Low of Suven Life Sciences Ltd?

Answer Field

The 52 Week High and Low of Suven Life Sciences Ltd for NSE is ₹ 299.99 and ₹ 124.11 and for BSE is ₹ 303.00 and ₹ 124.35.

What is 1 year return for Suven Life Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 19.03%.

What is the P/E Ratio of Suven Life Sciences Ltd Share?

Answer Field

As on Jun 11 2026 10:15 AM the price-to-earnings (PE) ratio for Suven Life Sciences Ltd share is -127.31.

What is the PB ratio of Suven Life Sciences Ltd Share?

Answer Field

As on Jun 11 2026 10:15 AM, the price-to-book (PB) ratio for Suven Life Sciences Ltd share is 57.00.

How to Buy Suven Life Sciences Ltd Share?

Answer Field

You can trade in Suven Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Suven Life Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Suven Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Suven Life Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|